Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 01/26/17 → 02/22/19 |
Funding
- Genentech Incorporated: $6,625.00
An Open-Label, Single-Arm Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients with Early Stage Relapsing Remitting Multiple Sclerosis
- Coyle, Patricia K (PI)
- McLinskey, Nancy (CoPI)
- Melville, Patricia (CoPI)
Project: Research